Hao J, Luo Q, Xiong G
Beijing Institute of Radiation Medicine, Beijing 100850, China.
Zhonghua Zhong Liu Za Zhi. 2001 Jan;23(1):21-4.
To study the therapeutic effect of recombinant human interleukin-11 (rhIL-11) on acute radiation sickness in monkeys.
rhIL-11 (30, 60, 120 micrograms.kg-1.d-1, s.c., on days 0-13 after TBI) or vehicle was administered to rhesus monkeys irradiated with 3.0 Gy 60Co gamma-rays.
The nadirs of platelet count were significantly improved after treatment with rhIL-11. The duration of platelet and leukocyte numbers below 50% of their baseline values was shortened. Erythrocyte recovery was also accelerated. Semi-solid bone marrow cell culture demonstrated that rhIL-11 could stimulate monkey's bone marrow cell to form more CFU-MK, CFU-Mix, CFU-E and BFU-E in vitro, especially at the dose of 60 micrograms.kg-1.d-1. Histopathological observation revealed that bone marrow of the untreated controls showed large area of bleeding whereas that of the rhIL-11 treated monkeys was in active proliferation.
rhIL-11 can accelerate hematopoietic recovery of monkeys received 3.0 Gy total body gamma-rays irradiation.